ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 16, 2025, titled "Glenmark Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma"
Announcement as on 16 December 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial".
Announcement as on 11 December 2025

Company Announcement
Update on the Company's Chhatrapati Sambhajinagar (Aurangabad) Facility
Announcement as on 01 December 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 27, 2025, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Monroe facility".
Announcement as on 27 November 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 25, 2025, titled "Glenmark Pharmaceuticals Announces Launch of Nebzmart® GFB Smartules® and Glenmark
Announcement as on 25 November 2025

Announcements by Glenmark Pharmaceuticals Limited first page | Next page | Prev page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2155.16
  • 12Day Average: 2160.11
  • 20Day Average: 2127.42
  • 50Day Average: 2047.38
  • 100Day Average: 1988.76
  • 150Day Average: 1985.38
  • 200Day Average: 1961.36

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2150.97, 2113.06, 43.58
Indicator MACD is in positive zone

Indicator ADX (14)

3.64, 24.92, 23.17
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Thu Mar 2026 2097.50 2087.40 to 2176.60 -4.06% 0.63 times
18 Wed Mar 2026 2186.30 2143.10 to 2237.60 1.88% 1.19 times
17 Tue Mar 2026 2145.90 2136.00 to 2184.70 -1.36% 1.04 times
16 Mon Mar 2026 2175.40 2145.00 to 2214.80 0.22% 0.71 times
13 Fri Mar 2026 2170.70 2163.70 to 2266.00 -3.8% 0.69 times
12 Thu Mar 2026 2256.40 2215.40 to 2273.20 -0.72% 1.34 times
11 Wed Mar 2026 2272.70 2228.00 to 2297.90 2.11% 1.24 times
10 Tue Mar 2026 2225.80 2130.40 to 2240.00 5.11% 2.09 times
09 Mon Mar 2026 2117.60 2050.20 to 2124.80 -0.32% 0.41 times
06 Fri Mar 2026 2124.40 2094.40 to 2138.00 0.73% 0.58 times
05 Thu Mar 2026 2108.90 2042.20 to 2118.90 3.39% 0.7 times
04 Wed Mar 2026 2039.70 2031.10 to 2110.50 -3.94% 0.56 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top